The Hemocompatibility of Nanoparticles: A Review of Cell–Nanoparticle Interactions and Hemostasis

Cells - Tập 8 Số 10 - Trang 1209
Kara M. de la Harpe1, Pierre P. D. Kondiah1, Yahya E. Choonara1, Thashree Marimuthu1, Lisa Du Toit1, Viness Pillay1
1Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Science, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa

Tóm tắt

Understanding cell–nanoparticle interactions is critical to developing effective nanosized drug delivery systems. Nanoparticles have already advanced the treatment of several challenging conditions including cancer and human immunodeficiency virus (HIV), yet still hold the potential to improve drug delivery to elusive target sites. Even though most nanoparticles will encounter blood at a certain stage of their transport through the body, the interactions between nanoparticles and blood cells is still poorly understood and the importance of evaluating nanoparticle hemocompatibility is vastly understated. In contrast to most review articles that look at the interference of nanoparticles with the intricate coagulation cascade, this review will explore nanoparticle hemocompatibility from a cellular angle. The most important functions of the three cellular components of blood, namely erythrocytes, platelets and leukocytes, in hemostasis are highlighted. The potential deleterious effects that nanoparticles can have on these cells are discussed and insight is provided into some of the complex mechanisms involved in nanoparticle–blood cell interactions. Throughout the review, emphasis is placed on the importance of undertaking thorough, all-inclusive hemocompatibility studies on newly engineered nanoparticles to facilitate their translation into clinical application.

Từ khóa


Tài liệu tham khảo

Matus, 2018, Nanotechnology and primary hemostasis: Differential effects of nanoparticles on platelet responses, Vasc. Pharmacol., 101, 1, 10.1016/j.vph.2017.11.004

Brash, J.L. (2018). Blood Compatibility of Nanomaterials. Drug Delivery Nanosystems for Biomedical Applications, Elsevier Inc.. Available online: https://doi.org/10.1016/B978-0-323-50922-0.00002-X.

Ritz, 2015, Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake, Biomacromolecules, 16, 1311, 10.1021/acs.biomac.5b00108

Sun, 2018, Nanotechnology-enabled materials for hemostatic and anti-infection treatments in orthopedic surgery, Int. J. Nanomed., 13, 8325, 10.2147/IJN.S173063

Zia, 2018, Platelet aggregation induced by polystyrene and platinum nanoparticles is dependent on surface area, Rsc Adv., 8, 37789, 10.1039/C8RA07315E

Khan, I., Saeed, K., and Khan, I. (2017). Nanoparticles: Properties, applications and toxicities. Arab. J. Chem.

Gobbo, 2015, Magnetic Nanoparticles in Cancer Theranostics, Theranostics, 5, 1249, 10.7150/thno.11544

Hajipour, 2017, Advances in Alzheimer’s Diagnosis and Therapy: The Implications of Nanotechnology, Trends Biotechnol., 35, 937, 10.1016/j.tibtech.2017.06.002

Sarmah, D., Saraf, J., Kaur, H., Pravalika, K., Tekade, R.K., Borah, A., Kalia, K., Dave, K.R., and Bhattacharya, P. (2017). Stroke Management: An Emerging Role of Nanotechnology. Micromachines, 8.

Szebeni, J., and Haima, P. (2013). Hemocompatibility of medical devices, blood products, nanomedicines and biologicals. TECOmedical Clinical & Technical Review, TECOmedical.

Scanlon, V.C., and Sanders, T. (2018). Essentials of Anatomy and Physiology, F.A. Davis.

Sorlie, 1981, Hematocrit and risk of coronary heart disease: The Puerto Rico Heart Health Program, Am. Hear. J., 101, 456, 10.1016/0002-8703(81)90136-8

Iwata, 2002, Activation of factor IX by erythrocyte membranes causes intrinsic coagulation, Blood Coagul. Fibrinolysis, 13, 489, 10.1097/00001721-200209000-00003

Byrnes, 2017, Red blood cells in thrombosis, Blood, 130, 1795, 10.1182/blood-2017-03-745349

Weisel, 2019, Red blood cells: The forgotten player in hemostasis and thrombosis, J. Thromb. Haemost., 17, 271, 10.1111/jth.14360

Du, 2013, New Insights into the Role of Erythrocytes in Thrombus Formation, Semin. Thromb. Hemost., 40, 72, 10.1055/s-0033-1363470

Mehri, R., Mavriplis, C., and Fenech, M. (2018). Red blood cell aggregates and their effect on non-Newtonian blood viscosity at low hematocrit in a two-fluid low shear rate microfluidic system. PLoS ONE, 13.

Sriram, 2014, Non-Newtonian flow of blood in arterioles: Consequences for wall shear stress measurements, Microcirculation, 21, 628, 10.1111/micc.12141

Walton, 2017, Elevated hematocrit enhances platelet accumulation following vascular injury, Blood, 129, 2537, 10.1182/blood-2016-10-746479

Brass, L.F., Tomaiuolo, M., Welsh, J., Poventud-Fuentes, I., Zhu, L., Diamond, S.L., and Stalker, T.J. (2019). Hemostatic Thrombus Formation in Flowing Blood, Elsevier.

Cooley, 2018, Influence of particle size and shape on their margination and wall-adhesion: Implications in drug delivery vehicle design across nano-to-micro scale, Nanoscale, 10, 15350, 10.1039/C8NR04042G

Wu, 2018, Significantly increased low shear rate viscosity, blood elastic modulus, and RBC aggregation in adults following cardiac surgery, Sci. Rep., 8, 7173, 10.1038/s41598-018-25317-8

Hod, 2015, New perspectives on the thrombotic complications of haemolysis, Br. J. Haematol., 168, 175, 10.1111/bjh.13183

Davenport, 2005, Pathophysiology of hemolytic transfusion reactions, Semin. Hematol., 42, 165, 10.1053/j.seminhematol.2005.04.006

Krajewski, 2013, Hemocompatibility evaluation of different silver nanoparticle concentrations employing a modified Chandler-loop in vitro assay on human blood, Acta Biomater., 9, 7460, 10.1016/j.actbio.2013.03.016

Mocan, 2013, Hemolysis as Expression of Nanoparticles-Induced Cytotoxicity in Red Blood Cells, Biotechnol Mol. Biol. Nanomedicine, 1, 7

Chen, 2015, Nanotoxicity of Silver Nanoparticles to Red Blood Cells: Size Dependent Adsorption, Uptake, and Hemolytic Activity, Chem. Res. Toxicol., 28, 501, 10.1021/tx500479m

Das, 2017, Surface modification minimizes the toxicity of silver nanoparticles: An in vitro and in vivo study, Jbic J. Boil. Inorg. Chem., 22, 893, 10.1007/s00775-017-1468-x

Yu, 2011, Impact of Silica Nanoparticle Design on Cellular Toxicity and Hemolytic Activity, Acs Nano, 5, 5717, 10.1021/nn2013904

Shang, 2014, Engineered nanoparticles interacting with cells: Size matters, J. Nanobiotechnology, 12, 5, 10.1186/1477-3155-12-5

Barshtein, G., Arbell, D., and Yedgar, S. (2018). Hemodynamic Functionality of Transfused Red Blood Cells in the Microcirculation of Blood Recipients. Front. Physiol., 9.

Avsievich, 2019, Mutual interaction of red blood cells influenced by nanoparticles, Sci. Rep., 9, 5147, 10.1038/s41598-019-41643-x

Jiang, 2019, Hemocompatibility investigation and improvement of near-infrared persistent luminescent nanoparticle ZnGa2O4:Cr3+ by surface PEGylation, J. Mater. Chem. B, 7, 3796, 10.1039/C9TB00378A

Neu, 2003, Cell-Cell Affinity of Senescent Human Erythrocytes, Biophys. J., 85, 75, 10.1016/S0006-3495(03)74456-7

Kim, 2014, Toxic effects of silver nanoparticles and nanowires on erythrocyte rheology, Food Chem. Toxicol., 67, 80, 10.1016/j.fct.2014.02.006

Han, 2012, Nanosize and Surface Charge Effects of Hydroxyapatite Nanoparticles on Red Blood Cell Suspensions, Acs Appl. Mater. Interfaces, 4, 4616, 10.1021/am300992x

Yedgar, 2002, The red blood cell in vascular occlusion, Pathophysiol. Haemost. Thromb., 32, 263, 10.1159/000073578

Geekiyanage, 2019, A coarse-grained red blood cell membrane model to study stomatocyte-discocyteechinocyte morphologies, PLoS ONE, 14, 1, 10.1371/journal.pone.0215447

Kim, 2015, Advances in the measurement of red blood cell deformability: A brief review, J. Cell. Biotechnol., 1, 63, 10.3233/JCB-15007

Kwaan, H.C., and Samama, M. (2019). Clinical Thrombosis, CRC Press.

Lin, 2012, The influence of nanodiamond on the oxygenation states and micro rheological properties of human red blood cells in vitro, J. Biomed. Opt., 17, 101512, 10.1117/1.JBO.17.10.101512

Zhao, 2011, Interaction of Mesoporous Silica Nanoparticles with Human Red Blood Cell Membranes: Size and Surface Effects, Acs Nano, 5, 1366, 10.1021/nn103077k

Kim, 2016, Hemorheological characteristics of red blood cells exposed to surface functionalized graphene quantum dots, Food Chem. Toxicol., 97, 346, 10.1016/j.fct.2016.09.034

He, 2014, The unexpected effect of PEGylated gold nanoparticles on the primary function of erythrocytes, Nanoscale, 6, 9017, 10.1039/C4NR01857E

Guo, 2018, Phosphatidylserine-exposing cells contribute to the hypercoagulable state in patients with multiple myeloma, Int. J. Oncol., 52, 1981

Ran, 2015, Eryptosis Indices as a Novel Predictive Parameter for Biocompatibility of Fe3O4 Magnetic Nanoparticles on Erythrocytes, Sci. Rep., 5, 16209, 10.1038/srep16209

Pan, 2018, Nanoparticle Properties Modulate Their Attachment and Effect on Carrier Red Blood Cells, Sci. Rep., 8, 1615, 10.1038/s41598-018-19897-8

Clemetson, 2012, Platelets and Primary Haemostasis, Thromb. Res., 129, 220, 10.1016/j.thromres.2011.11.036

Broos, 2011, Platelets at work in primary hemostasis, Blood Rev., 25, 155, 10.1016/j.blre.2011.03.002

Holinstat, 2017, Normal platelet function, Cancer Metastasis Rev., 36, 195, 10.1007/s10555-017-9677-x

Mancuso, 2017, Platelets: Much more than bricks in a breached wall, Br. J. Haematol., 178, 209, 10.1111/bjh.14653

Bergmeier, 2018, Platelets at the vascular interface, Res. Pract. Thromb. Haemost., 2, 27, 10.1002/rth2.12061

Zaidi, 2019, Physiology of haemostasis, Anaesth. Intensiv. Care Med., 20, 152, 10.1016/j.mpaic.2019.01.005

Corbalan, 2012, Amorphous silica nanoparticles aggregate human platelets: Potential implications for vascular homeostasis, Int. J. Nanomed., 7, 631

Saikia, 2018, Silica Nanoparticle–Endothelial Interaction: Uptake and Effect on Platelet Adhesion under Flow Conditions, ACS Appl. Bio Mater., 1, 1620, 10.1021/acsabm.8b00466

Feng, 2019, Silica nanoparticles trigger the vascular endothelial dysfunction and prethrombotic state via miR-451 directly regulating the IL6R signaling pathway, Part. Fibre Toxicol., 16, 16, 10.1186/s12989-019-0300-x

Wang, 2013, Platelets in Thrombosis and Hemostasis: Old Topic with New Mechanisms, Cardiovasc. Hematol. Disord. Targets, 12, 126, 10.2174/1871529X11202020126

Austin, 2017, Haemostasis, Medicine (United Kingdom), 45, 204

Radomska, 2016, The Nanopharmacology and Nanotoxicology of Nanomaterials: New Opportunities and Challenges, Adv. Clin. Exp. Med., 25, 151, 10.17219/acem/60879

Radomski, 2005, Nanoparticle-induced platelet aggregation and vascular thrombosis, Br. J. Pharmacol., 146, 882, 10.1038/sj.bjp.0706386

Caminade, A.-M., and Majoral, J.-P. (2018). Which Dendrimer to Attain the Desired Properties? Focus on Phosphorhydrazone Dendrimers†. Molecules, 23.

Greish, 2012, Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles, Nanotoxicology, 6, 713, 10.3109/17435390.2011.604442

Jones, 2012, Cationic PAMAM dendrimers disrupt key platelet functions, Mol. Pharm., 9, 1599, 10.1021/mp2006054

Simak, 2017, The effects of nanomaterials on blood coagulation in hemostasis and thrombosis, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnology, 9, e1448, 10.1002/wnan.1448

Dobrovolskaia, M.A., and McNeil, S.E. (2016). The effects of engineered nanomaterials on platelets. Handbook of Immunological Properties of Engineered Nanomaterials, World Scientific.

Shah, 2013, Blood protein and blood cell interactions with gold nanoparticles: The need for in vivo studies, BioNanoMaterials, 14, 65, 10.1515/bnm-2012-0003

Gorbet, 2019, The blood compatibility challenge. Part 3: Material associated activation of blood cascades and cells, Acta Biomater., 94, 25, 10.1016/j.actbio.2019.06.020

Swystun, 2019, The role of leukocytes in thrombosis, Blood, 128, 753, 10.1182/blood-2016-05-718114

Gieseck, 2018, Type 2 immunity in tissue repair and fibrosis, Nat. Rev. Immunol., 18, 62, 10.1038/nri.2017.90

Baharom, 2017, Human Lung Mononuclear Phagocytes in Health and Disease, Front. Immunol., 8, 499, 10.3389/fimmu.2017.00499

Putzu, 2014, Leucocyte classification for leukaemia detection using image processing techniques, Artif. Intell. Med., 62, 179, 10.1016/j.artmed.2014.09.002

Kowalska, 2010, Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis, Thromb. Res., 125, 292, 10.1016/j.thromres.2009.11.023

Shantsila, 2009, The role of monocytes in thrombotic disorders: Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms, Thromb. Haemost., 102, 916, 10.1160/TH09-01-0023

Laridan, 2019, Neutrophil extracellular traps in arterial and venous thrombosis, Seminars in Thrombosis and Hemostasis, Volume 45, 86, 10.1055/s-0038-1677040

Sotiri, 2019, BloodSurf 2017: News from the blood-biomaterial frontier, Acta Biomater., 87, 55, 10.1016/j.actbio.2019.01.032

Sperling, C., Maitz, M.F., and Werner, C. (2017). Test methods for hemocompatibility of biomaterials. Hemocompatibility of Biomaterials for Clinical Applications: Blood-Biomaterials Interactions, Elsevier Ltd.

Gustafson, 2015, Nanoparticle uptake: The phagocyte problem, Nano Today, 10, 487, 10.1016/j.nantod.2015.06.006

Bartneck, 2010, Rapid Uptake of Gold Nanorods by Primary Human Blood Phagocytes and Immunomodulatory Effects of Surface Chemistry, Acs Nano, 4, 3073, 10.1021/nn100262h

Huang, 2010, Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review), Mol. Membr. Boil., 27, 190, 10.3109/09687688.2010.499548

Ge, 2015, Towards understanding of nanoparticle–protein corona, Arch. Toxicol., 89, 519, 10.1007/s00204-015-1458-0

Karmali, 2011, Interactions of nanoparticles with plasma proteins: Implication on clearance and toxicity of drug delivery systems, Expert Opin. Drug Deliv., 8, 343, 10.1517/17425247.2011.554818

Pires, 2017, Avoiding the mononuclear phagocyte system using human albumin for mesoporous silica nanoparticle system, Microporous Mesoporous Mater., 251, 181, 10.1016/j.micromeso.2017.06.005

Vu, 2019, Immunoglobulin deposition on biomolecule corona determines complement opsonisation efficiency of preclinical and clinical nanoparticles, Nat. Nanotechnol., 14, 260, 10.1038/s41565-018-0344-3

Lee, 2014, Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity, Int. J. Nanomed., 10, 97

Lin, 2018, The Interplay between Nanoparticles and Neutrophils, J. Biomed. Nanotechnol., 14, 66, 10.1166/jbn.2018.2459

Batt, 2018, TiO2 nanoparticles can selectively bind CXCL8 impacting on neutrophil chemotaxis, Eur. Cells Mater., 35, 13, 10.22203/eCM.v035a02

Kojouri, 2012, The effects of oral consumption of selenium nanoparticles on chemotactic and respiratory burst activities of neutrophils in comparison with sodium selenite in sheep, Biol. Trace Elem. Res., 146, 160, 10.1007/s12011-011-9241-4

Durocher, 2017, Evaluation of the in vitro and in vivo proinflammatory activities of gold (+) and gold (−) nanoparticles, Inflamm. Res., 66, 981, 10.1007/s00011-017-1078-7

Herrmann, 2011, Iron core/shell nanoparticles as magnetic drug carriers: Possible interactions with the vascular compartment, Nanomedicine, 6, 1199, 10.2217/nnm.11.33

Tamassia, 2018, Cytokine production by human neutrophils: Revisiting the “dark side of the moon.”, Eur. J. Clin. Investig., 48, e12952, 10.1111/eci.12952

Rungelrath, V., Kobayashi, S.D., and DeLeo, F.R. (2019). Neutrophils in innate immunity and systems biology-level approaches: An update. Wiley Interdiscip Rev Syst Biol Med.

Nolte, 2014, Endotoxins affect diverse biological activity of chitosans in matters of hemocompatibility and cytocompatibility, J. Mater. Sci. Mater. Electron., 25, 2121, 10.1007/s10856-014-5244-y

Sarmento, 2015, Evaluation of Hemagglutination Activity of Chitosan Nanoparticles Using Human Erythrocytes, Biomed. Res. Int., 2015, 1

Dolati, 2016, Utilization of nanoparticle technology in rheumatoid arthritis treatment, Biomed. Pharmacother., 80, 30, 10.1016/j.biopha.2016.03.004

Wang, 2008, Genetic Vaccines and Therapy, Genet Vaccines Ther., 9, 1

Mudgal, 2019, Immunomodulatory role of chitosan-based nanoparticles and oligosaccharides in cyclophosphamide-treated mice, Scand. J. Immunol., 89, e12749, 10.1111/sji.12749

Hwang, 2015, Cationic additives in nanosystems activate cytotoxicity and inflammatory response of human neutrophils: Lipid nanoparticles versus polymeric nanoparticles, Int. J. Nanomed., 10, 371

Chua, 2006, Neutrophil Elastase: Mediator of Extracellular Matrix Destruction and Accumulation, Proc. Am. Thorac. Soc., 3, 424, 10.1513/pats.200603-078AW

Sandri, 2019, Direct effects of poly(ε-caprolactone) lipid-core nanocapsules on human immune cells, Nanomedicine, 14, 1429, 10.2217/nnm-2018-0484

Adjei, I.M., Plumton, G., and Sharma, B. (2016). Oxidative Stress and Biomaterials: The Inflammatory Link. Oxidative Stress and Biomaterials, Elsevier Inc.

Pleskova, 2019, Characteristics of quantum dots phagocytosis by neutrophil granulocytes, Heliyon, 5, e01439, 10.1016/j.heliyon.2019.e01439

Skivka, 2018, C60 fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytes, Cancer Nanotechnol., 9, 8, 10.1186/s12645-017-0034-0

Chen, 2016, In vivo and in vitro evaluation of hydroxyapatite nanoparticle morphology on the acute inflammatory response, Biomaterials, 90, 1, 10.1016/j.biomaterials.2016.02.039

Yang, 2016, Cationic liposomes induce cell necrosis through lysosomal dysfunction and late-stage autophagic flux inhibition, Nanomedicine, 11, 3117, 10.2217/nnm-2016-0289

Knudsen, 2015, In vivo toxicity of cationic micelles and liposomes, Nanomed. Nanotechnol. Boil. Med., 11, 467, 10.1016/j.nano.2014.08.004

Bae, 2018, Diacylglycerol in Cationic Nanoparticles Stimulates Oxidative Stress-Mediated Death of Cancer Cells, Lipids, 53, 1059, 10.1002/lipd.12124

Hwang, 2015, The impact of cationic solid lipid nanoparticles on human neutrophil activation and formation of neutrophil extracellular traps (NETs), Chem. Interact., 235, 106, 10.1016/j.cbi.2015.04.011

Lotosh, 2019, Cationic Liposomes Cause ROS Generation and Release of Neutrophil Extracellular Traps, Biochem. (Mosc.) Suppl. Ser. A: Membr. Cell Boil., 13, 40, 10.1134/S1990747818040074

Blanco, 2015, Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nat. Biotechnol., 33, 941, 10.1038/nbt.3330

Yong, 2017, Mononuclear phagocytes as a target, not a barrier, for drug delivery, J. Control. Release., 259, 53, 10.1016/j.jconrel.2017.01.024

Zanganeh, S., Spitler, R., Javdani, N., and Ho, J.Q. (2017). How do Nanoparticles (NPs) Pass Barriers?. Drug Delivery Systems, World Scientific.

Li, 2018, Immunotoxicity of Silver Nanoparticles (AgNPs) on the Leukocytes of Common Bottlenose Dolphins (Tursiops truncatus), Sci. Rep., 8, 1

Babin, 2015, Nanoparticles enhance the ability of human neutrophils to exert phagocytosis by a Syk-dependent mechanism, Biochim. Biophys. Acta – Gen. Subj., 1850, 2276, 10.1016/j.bbagen.2015.08.006

Stern, 2008, Role for nanomaterial-autophagy interaction in neurodegenerative disease, Autophagy, 4, 1097, 10.4161/auto.7142

Colognato, 2008, Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitro, Mutagenesis, 23, 377, 10.1093/mutage/gen024

Jiang, 2012, Effects of cobalt nanoparticles on human T cells in vitro, Biol. Trace Elem. Res., 146, 23, 10.1007/s12011-011-9221-8

Crist, 2014, Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity, Part. Fibre Toxicol., 9, 20

Sohaebuddin, 2010, Nanomaterial cytotoxicity is composition, size, and cell type dependent, Part. Fibre Toxicol., 7, 1, 10.1186/1743-8977-7-22

Xia, 2008, Cationic Polystyrene Nanosphere, ACS Nano, 2, 85, 10.1021/nn700256c

Thomas, 2009, Cationic poly(amidoamine) dendrimer induces lysosomal apoptotic pathway at therapeutically relevant concentrations, Biomacromolecules, 10, 3207, 10.1021/bm900683r

Futerman, 2004, The cell biology of lysosomal storage disorders, Nat. Rev. Mol. Cell Biol., 5, 554, 10.1038/nrm1423

He, 2009, Regulation Mechanisms and Signaling Pathways of Autophagy, Annu. Rev. Genet., 43, 67, 10.1146/annurev-genet-102808-114910

Chen, 2005, Nano neodymium oxide induces massive vacuolization and autophagic cell death in non-small cell lung cancer NCI-H460 cells, Biochem. Biophys. Res. Commun., 337, 52, 10.1016/j.bbrc.2005.09.018

Peifley, 2010, Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction, Toxicol. Appl. Pharmacol., 248, 249, 10.1016/j.taap.2010.08.008

Zhang, 2011, Size-dependent in vivo toxicity of PEG-coated gold nanoparticles, Int. J. Nanomedicine, 6, 2071, 10.2147/IJN.S21657

Buzea, 2007, Nanomaterials and nanoparticles: Sources and toxicity, Biointerphases, 2, MR17, 10.1116/1.2815690

Zhao, 2011, Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials, Small, 7, 1322, 10.1002/smll.201100001

Simard, 2016, Gold nanoparticles induce apoptosis, endoplasmic reticulum stress events and cleavage of cytoskeletal proteins in human neutrophils, Toxicol. Vitr., 31, 12, 10.1016/j.tiv.2015.11.003

Best, 2012, The role of particle geometry and mechanics in the biological domain, Adv. Healthc. Mater., 1, 35, 10.1002/adhm.201100012

Decuzzi, 2008, The receptor-mediated endocytosis of nonspherical particles, Biophys. J., 94, 3790, 10.1529/biophysj.107.120238

Gratton, 2008, The effect of particle design on cellular internalization pathways, Proc. Natl. Acad. Sci. USA, 105, 11613, 10.1073/pnas.0801763105

Park, 2018, Fibrous nanocellulose, crystalline nanocellulose, carbon nanotubes, and crocidolite asbestos elicit disparate immune responses upon pharyngeal aspiration in mice, J. Immunotoxicol., 15, 12, 10.1080/1547691X.2017.1414339

Denis, 2002, Protein adsorption on model surfaces with controlled nanotopography and chemistry, Langmuir, 18, 819, 10.1021/la011011o

Ferraz, 2010, Procoagulant behavior and platelet microparticle generation on nanoporous alumina, J. Biomater. Appl., 24, 675, 10.1177/0885328209338639

Yu, 2012, Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: Their vasculature effect and tolerance threshold, ACS Nano, 6, 2289, 10.1021/nn2043803

Murugadoss, 2017, Toxicology of silica nanoparticles: An update, Arch. Toxicol., 91, 2967, 10.1007/s00204-017-1993-y

Yang, 2010, Crystallization behavior of poly(ε-caprolactone)/layered double hydroxide nanocomposites, J. Appl. Polym. Sci., 116, 2658, 10.1002/app.31787

Ban, 2016, Protein corona over silver nanoparticles triggers conformational change of proteins and drop in bactericidal potential of nanoparticles: Polyethylene glycol capping as preventive strategy, Colloids Surfaces B Biointerfaces., 146, 577, 10.1016/j.colsurfb.2016.06.050

Hakim, 1988, Role of erythrocyte deformability in the acute hypoxic pressor response in the pulmonary vasculature, Respir Physiol., 72, 95, 10.1016/0034-5687(88)90082-5

Guo, 2014, Assessment of the toxic potential of graphene family nanomaterials, J. Food Drug Anal., 22, 105, 10.1016/j.jfda.2014.01.009

Shvedova, 2010, Close Encounters of the Small Kind: Adverse Effects of Man-Made Materials Interfacing with the Nano-Cosmos of Biological Systems, Annu. Rev. Pharmacol. Toxicol., 50, 63, 10.1146/annurev.pharmtox.010909.105819

Palmer, 2014, Annual review of biomedical engineering, Blood Substit., 16, 77

Nel, 2013, Implementation of alternative test strategies for the safety assessment of engineered nanomaterials, J. Intern. Med., 274, 561, 10.1111/joim.12109